157 related articles for article (PubMed ID: 3760271)
1. Treatment of basal cell carcinoma with intralesional interferon.
Greenway HT; Cornell RC; Tanner DJ; Peets E; Bordin GM; Nagi C
J Am Acad Dermatol; 1986 Sep; 15(3):437-43. PubMed ID: 3760271
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neoplastic skin lesions with intralesional interferon.
Wickramasinghe L; Hindson TC; Wacks H
J Am Acad Dermatol; 1989 Jan; 20(1):71-4. PubMed ID: 2913082
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma treated with interferon.
Ikić D; Padovan I; Pipić N; Knezević M; Djaković N; Rode B; Kosutić I; Belicza M
Int J Dermatol; 1991 Oct; 30(10):734-7. PubMed ID: 1955231
[TBL] [Abstract][Full Text] [Related]
5. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.
Edwards L; Tucker SB; Perednia D; Smiles KA; Taylor EL; Tanner DJ; Peets E
Arch Dermatol; 1990 Aug; 126(8):1029-32. PubMed ID: 2383027
[TBL] [Abstract][Full Text] [Related]
6. The effect of intralesional interferon gamma on basal cell carcinomas.
Edwards L; Whiting D; Rogers D; Luck K; Smiles KA
J Am Acad Dermatol; 1990 Mar; 22(3):496-500. PubMed ID: 2107219
[TBL] [Abstract][Full Text] [Related]
7. Intralesional interferon therapy for basal cell carcinoma.
Cornell RC; Greenway HT; Tucker SB; Edwards L; Ashworth S; Vance JC; Tanner DJ; Taylor EL; Smiles KA; Peets EA
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):694-700. PubMed ID: 2229497
[TBL] [Abstract][Full Text] [Related]
8. Intralesional alfa-2a interferon therapy for basal cell carcinoma.
Doğan B; Harmanyeri Y; Baloğlu H; Oztek I
Cancer Lett; 1995 May; 91(2):215-9. PubMed ID: 7767912
[TBL] [Abstract][Full Text] [Related]
9. Intralesional alpha 2b recombinant interferon for basal cell carcinomas.
Boneschi V; Brambilla L; Chiappino G; Mozzanica N; Finzi AF
Int J Dermatol; 1991 Mar; 30(3):220-4. PubMed ID: 2037410
[No Abstract] [Full Text] [Related]
10. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.
Kowalzick L; Rogozinski T; Wimheuer R; Pilz J; Manske U; Scholz A; Fierlbeck G; Mohr P; Ochsendorf F; Wagner G; Gaus W; Brzoska J; Jablonska S
Eur J Dermatol; 2002; 12(6):558-61. PubMed ID: 12459527
[TBL] [Abstract][Full Text] [Related]
11. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
12. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
13. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.
Kim KH; Yavel RM; Gross VL; Brody N
Dermatol Surg; 2004 Jan; 30(1):116-20. PubMed ID: 14692941
[TBL] [Abstract][Full Text] [Related]
14. Treatment of basal cell carcinoma with surgical excision and perilesional interferon-α.
Wettstein R; Erba P; Itin P; Schaefer DJ; Kalbermatten DF
J Plast Reconstr Aesthet Surg; 2013 Jul; 66(7):912-6. PubMed ID: 23566745
[TBL] [Abstract][Full Text] [Related]
15. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394
[TBL] [Abstract][Full Text] [Related]
16. Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas.
Gyurova MS; Stancheva MZ; Arnaudova MN; Yankova RK
Dermatol Online J; 2006 Mar; 12(3):25. PubMed ID: 16638439
[TBL] [Abstract][Full Text] [Related]
17. Intralesional interferon-alpha 2b treatment of basal cell carcinoma.
Thestrup-Pedersen K; Jacobsen IE; Frentz G
Acta Derm Venereol; 1990; 70(6):512-4. PubMed ID: 1981427
[TBL] [Abstract][Full Text] [Related]
18. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery.
Stenquist B; Wennberg AM; Gisslén H; Larkö O
J Am Acad Dermatol; 1992 Jul; 27(1):65-9. PubMed ID: 1619079
[TBL] [Abstract][Full Text] [Related]
19. Treatment of basal cell carcinoma with intralesional interferon alpha: a case report and literature review.
McDonald RR; Georgouras K
Australas J Dermatol; 1992; 33(2):81-6. PubMed ID: 1294057
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients.
Vidal D; Alomar A
Clin Exp Dermatol; 2004 May; 29(3):237-9. PubMed ID: 15115500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
